Data / Form D filings / GENHEALTH, INC.
GENHEALTH, INC.: Form D filings
GENHEALTH, INC., a biotechnology company in Vienna, VA, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on September 29, 2026, reports $16.5 million sold of a $16.5 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 520 LEWIS ST NW, Vienna, VA, 22180
- Phone
- (786) 351-0609
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1980883
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | New notice | $16,499,983 | $16,499,983 | 8 | Aug 4, 2026 | sec.gov | |
| Jun 9, 2023 | New notice | $13,249,994 | $12,999,995 | $249,999 | 3 | May 25, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ritwik Sahu | Executive Officer, Director | |
| Ethan Siegel | Director | |
| Kahini Shah | Director | |
| Victor Lanio | Director |
Other biotechnology companies in Virginia that filed recently
- SalivIQ Diagnostics Inc. $1.9 million · Sep 23, 2026
Every Form D from the week of Sep 28, 2026 · All recent filings in Virginia · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GENHEALTH, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.